sunnex biotech

Establishing Blue Light Exposure Contributes to the Development of AMD

That increased macular pigment optical density (MPOD) is protective of AMD, and is independent from other risk factors for AMD, would provide a logically sufficient basis for demonstrating that blue light exposure contributes to the development of AMD*. Macular pigment (MP) is located in the inner retina above the macular region of the retina. Light must pass through this layer of MP to reach the macular region of the outer retina. The outer retina contains the photoreceptor cells, retinal pigment epithelial (RPE) cells and the Bruch’s membrane complex. It is in the macular region of the outer retina where AMD develops, and is manifested through the malfunctioning of these cells and the alteration of the properties of Bruch`s membrane.

MP is a blue-light absorbing yellow pigment containing the xanthophyll carotenoids, lutein, zeaxanthin and meso-zeaxanthin. In some people macular pigment prevents up to 95% of incident blue light wavelengths from reaching the outer retina. Macular pigment density can be regulated by diet, specifically by consumption of the carotenoids lutein and zeaxanthin. The amount of blue light reaching the outer retina is inversely proportional to macular pigment density. There is a growing consensus that an increased density of MP, and the corresponding reduction in blue light reaching the outer retina, results in a substantial delay in the onset of AMD.1, 1a

As the layer of macular pigment is located in the inner retina, it is remote from the metabolic activities involved in the pathogenesis of AMD which occur in the outer retina. The generation of radical oxygen species(ROS) in RPE cells and the resulting increase in oxidative retinal stress in the outer retina is integral to the development of AMD. The primary mechanisms generating ROS in RPE cells are dependent upon, or substantially enhanced by, the absorption of blue light. Therefore increased absorption of sub-lethal amounts of blue light by RPE cells contributes to increased generation of ROS. When ROS levels exceed the RPE cell's antioxidative capacity, the result is increased levels of retinal oxidative stress and increased inducement of the inflammatory response.

The most obvious manner by which an increased density of MP can influence the development of AMD is through the reduction of ROS-generating blue light that reaches the outer retina, thus reducing the production of ROS and the retinal stress in that retinal region. However, because the retina is very thin in the region of the foveal pit, which is located near the center of the macula, and constituent macular carotenoid molecules have been found in photoreceptor cells in that region, some have posited that it is the increased levels of these carotenoid molecules, which do have strongly anti-oxidative properties, that give rise to the protective quality of increased macular pigment density. The possibility cannot yet be ruled out that of the multitude of endogenous and nutritional molecules that contribute to protection of the retina from oxidative stress, an increased number of carotenoid molecules in the macular pigment is a dominant protective factor.

With respect to the role of blue light in promoting the development of AMD, it is immaterial the extent to which the protection from AMD provided by increased macular pigment density results from limiting the amount of ROS-generating blue light that reaches the outer retina, or the extent ot which this protection results from the neutralization of radical oxygen species generated by the absorption of blue light in the outer retina. Increased oxidative retinal stress and the resulting chronic low grade inflammation in the outer retina is integral to the development of AMD.2,3 Therefore, a measurable inverse relationship between macular pigment density and susceptibility to AMD establishes that blue light exposure contributes substantially to the development of AMD.

NOTE: As it has now been established that hazardous blue light wavelengths (wavelengths shorter than 480 nm) are not necessary for effective and efficient light therapy, and that the inclusion of these wavelength provides no benefit for light therapy. Therefore these wavelengths have been eliminated from the emission spectrum of the Sunnex Biotechnologies Lo-LIGHT therapy lamp. MORE.
It has also been independently established that human circadian physiology is more sensitive to Sunnex Biotechnologies' GreenLIGHT lamps than to light provided by competitors' blue and blue-enhanced light therapy lamps. MORE.

1. The following is taken from an interview with Dr. Paul Bernstein, one of the foremost experts on the formation and function of macular pigment, as quoted in Ophthalmology Times Europe, Apr 1, 2010. “Lutein and zeaxanthin are concentrated specifically in the macula and are derived exclusively from the diet. They act as antioxidants and light-screening compounds in the eye," he said. "The Eye Disease Case-Control Study showed that there is an inverse correlation between serum carotenoid levels and exudative AMD."
In a subsequent ancillary study, subjects who consumed the highest levels of lutein and zeaxanthin from sources such as spinach and collard greens had a 43% lower risk of AMD, Dr Bernstein said.
"Our research has shown that there is a decrease in the levels of macular pigment in patients at risk of developing AMD," he said. "About thirty percent lower levels of macular pigment are found in patients with AMD or those who are at high risk of AMD. These levels can be modified by the diet."
The location of the carotenoids in the retina is ideal to screen blue light. Animals raised on carotenoid-free diets appear to be more susceptible to light damage in their retinas, according to Dr Bernstein.

1a. The following is taken from a report on a panel discussion by a group of experts on the relationship between Macular Pigment Optical Density and AMD held at the American Optometry Association in June 2010.
The panel discussion was titled "The Value of Macular Pigment Optical Density (MPOD) for Age-Related Eye Diseases and Visual Performance." The panel of experts including Paul S. Bernstein, M.D., Francois C. Delori, Stuart Richer, Erik J.M. van Kuijk and Adam J. Wenzel collectively reviewed the scientific literature. A key conclusion from the panel presented at a press conference was that "The current body of evidence supports the hypothesis that AMD is in part a manifestation of an ocular deficiency of lutein and zeaxanthin and that higher macular levels may protect against AMD." The report further explains - "MPOD is a measurement of the attenuation of blue light by the macular pigment and is linearly related to the amount of lutein and zeaxanthin in the macula. More than 250 published studies support that the macular pigments, lutein and zeaxanthin, are essential nutrients for maintaining healthy vision."
For full report "click here".

2. See The Role of Blue Light in the Pathogenesis of AMD

3. See A draft update to The Role of Blue Light in the Pathogenesis of AMD

* Scientific inference can be used to establish a conclusion derived from logical deductions from valid premises. We propose that the following 4 premises are sufficient to establish that blue light exposure substantially advances the onset of AMD. Based on the considerable published evidence that supports each of these 4 statements, there appears to be a general consensus on the validity of these premises. Thus, while there are many gaps in the understanding of the pathogenesis of AMD, it can still be established that blue light exposure substantially contributes to the pathological development of this debilitating condition. The 4 premises are:
1) Chronic low grade inflammation in RPE cells is implicated in the pathogenesis of AMD.
2) The inflammatory response in the outer retina, which includes activation of the complement system, is induced by heightened levels of oxidative stress in the outer retina.
3) Light absorption contributes significantly to the generation of ROS in the outer retina. Blue light absorption (i.e. absorption of visible light with wavelengths shorter than 480 nm) is primarily responsible for photo-induced generation of ROS in the outer retina. This includes ROS generation within RPE cells resulting from absorption of light by mitochondria, nuclear DNA, lipofuscin, and remnants of photoreceptor cells, as well as by light absorption by photoreceptor remnants located in basal deposits and drusen adjacent to RPE cells and the Bruch’s membrane. Photic induction of ROS in the outer retina raises the level of oxidative stress in that region.
4) Macular pigment optical density (MPOD) is an independent risk factor for AMD. While the acceptance of this premise is not universal, and some are awaiting the confirmation of this by AREDS II, a large scale study which is seeking to establish the veracity of this premise, there appears to be a growing consensus amongst those researchers most actively examining the effects of increased MP density that this is now established, and that the determination of this reflects a substantial time difference (several years) between the development of AMD in people with high MPOD as compared with people with low MPOD.

Note: Scientific inference is a process by which a valid conclusion is arrived at through sound logical deduction based on a set of reasonable premises. Scientific inference, or logical deduction, is an essential process of science and widely used in theoretical physics and chemistry. In biology, however, scientific inference is not often applicable because the complexity of biological systems makes it difficult to formulate an adequate set of well established premises to describe the aspects of a biological system from which a logical conclusion can be derived.
Sufficient knowledge now appears to exist to allow scientific inference to be used to determine the role that cumulative blue light exposure has on the development of AMD. Determination that the derived conclusion is not valid would rest on the demonstration that either one or more of the premises used are not correct, that a significant element has not been included in the premises, or that the process of logical deduction is faulty. Thus, if at any time the conclusion would be found to at variance with valid empirical results, this would establish that either one or more of the premises are not correct, significant information was not included in the premises, or that the process of logical deduction was flawed.
Therefore the conclusion that Cummulative Blue Light Exposure Substantially Promotes the Development of Age-related Macular Degeneration (AMD) is scientifically valid unless it can be established that;
1) one of the 4 premises stated above is not valid, or
2)an alternate mechanism based on empirical evidence can be proposed in which increased macular pigment optical density can reduce the incidence of AMD without reducing the level of retinal oxidative stress resulting either from the generation of ROS by the absorption of blue light in the outer retina region, or by the reduction of oxidative stress in the outer retina through anti-oxidative actions of the constituent carotenoids of macular pigment.

For more information, please call Sunnex Biotechnologies at 1-877-778-6639.

To the Sunnex Biotechnologies Home Page